Bliss GVS Pharma Ltd

NSE: BLISSGVS · BSE: 506197 · Pharmaceuticals & Biotechnology · 6 announcements

Share price: ₹704.70
Market cap: ₹7,493 Cr
Revenue (annual): ₹927.1 Cr
Net profit (annual): ₹129.1 Cr
P/E (TTM): 55.0×Sector 50.4×
Promoter holding: 35.01%-0.35% QoQ
FII holding: 8.07%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 2 Employee Stock Options 2 Open Offer 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

22 Sep 2026 16:00 IST BSE

Annual General Meeting

Bliss GVS Pharma Annual General Meeting

Bliss GVS Pharma Ltd reported the voting results of its postal ballot. Members approved the appointment of Mr. Santosh Parab as a Non-Executive and Non-Independent Director.

Read the filing ↗